{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:24Z","timestamp":1747207344293,"version":"3.40.5"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"21","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Acne is a highly prevalent disease that mainly affects the pilosebaceous\nunits associated with sebaceous glands, causing inflammatory skin lesions and affecting\nthe self-esteem, mental health, and quality of life of those who suffer from this\ndisease. Different treatments exist today to prevent, reduce, and improve symptoms; however,\nover the years, there have been problems with bacterial resistance and slight effectiveness\nwith prolonged use.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The purpose of this article is based on the review of patents of new products of\nprincipal topical administration for the treatment of acne in recent years 2016-2020, to\nevaluate and analyze novel synthetic molecules and semi-synthetics with potential therapeutic\nand preventive in the acne treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A systematic review of patents was conducted through the official database of\nthe European Patent Office - Espacenet, where the search focused on the keywords: \"acne\nand bacteria\" in the title or abstract. Only patents granted between the years 2016-2020\nwere included, with products having molecules with a synthetic and semi-synthetic origin,\nwithout considering natural, biological products or those used as diagnostic means.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 19 patents were selected, most with principally antimicrobial and antiinflammatory\naction, where the reduction in the appearance of resistance by C. acnes is\nverified, and its action is complemented by inhibiting the different pathophysiological\nmechanisms that lead to the worsening of the disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Novel approaches in the treatment and prevention of acne, mainly topically,\nare focused on the reduction of bacterial resistance and irritation compared to current\ntreatments. The use of combined formulations provides better results with additional benefits,\nimproving treatment times and patient adherence.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230817155906","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T05:12:35Z","timestamp":1692335555000},"page":"3182-3197","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Molecules of Importance in the Prevention and Treatment of\nAcne: A Systematic Patent Review (2016-2020)"],"prefix":"10.2174","volume":"31","author":[{"given":"Daniela Estefan\u00eda","family":"Calder\u00f3n-Pardo","sequence":"first","affiliation":[{"name":"Departamento de Farmacia, Facultad de Ciencias, Universidad Nacional de Colombia, Bogot\u00e1 D.C., Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairim Russo","family":"Serafini","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o, Sergipe, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabel Almeida","family":"Alves","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2862-3771","authenticated-orcid":true,"given":"Diana Marcela","family":"Arag\u00f3n","sequence":"additional","affiliation":[{"name":"Departamento de Farmacia, Facultad de Ciencias, Universidad Nacional de Colombia, Bogot\u00e1 D.C., Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.det.2011.09.001","volume":"30","author":"Knutsen-Larson S.","year":"2012","unstructured":"Knutsen-Larson S.; Dawson A.L.; Dunnick C.A.; Dellavalle R.P.; Acne vulgaris: Pathogenesis, treatment, and needs assessment. Dermatol Clin  viii-ix.2012,30(1),99-106","journal-title":"Dermatol Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"Williams H.C.","year":"2012","unstructured":"Williams H.C.; Dellavalle R.P.; Garner S.; Acne vulgaris. Lancet  2012,379(9813),361-372","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jdv.12224","volume":"28","author":"Beylot C.","year":"2014","unstructured":"Beylot C.; Auffret N.; Poli F.; Claudel J.P.; Leccia M.T.; Del Giudice P.; Dreno B.; Propionibacterium acnes: An update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol  2014,28(3),271-278","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"E430","DOI":"10.1503\/cmaj.090374","volume":"183","author":"Kraft J.","year":"2011","unstructured":"Kraft J.; Freiman A.; Management of acne. CMAJ  2011,183(7),E430-5","journal-title":"CMAJ"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/molecules21081063","volume":"21","author":"Fox L.","year":"2016","unstructured":"Fox L.; Csongradi C.; Aucamp M.; du Plessis J.; Gerber M.; Treatment modalities for acne. Molecules  2016,21(8),1063","journal-title":"Molecules"},{"year":"2020","key":"ref=6","unstructured":"Global Innovation Index. 13th edition. SC Johnson College of Business, World International Property (WIPO) Avialable from:  https:\/\/www.wipo.int\/global_innovation_ index\/en\/2020\/2020"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e14287","DOI":"10.1111\/dth.14287","volume":"33","author":"Zhao J.","year":"2020","unstructured":"Zhao J.; Wang Y.; Jiang L.; Mu Y.Z.; The application of skin care product in acne treatment. Dermatol Ther  2020,33(6),e14287","journal-title":"Dermatol Ther"},{"year":"2022","key":"ref=8","unstructured":"South Korea \u2013 Country Commercial Guide. International Trade Administration Avialable from:  https:\/\/www. trade.gov\/country-commercial-guides\/south-korea-cosme-tics2022"},{"year":"2023","key":"ref=9","unstructured":"IPC Publication. WIPO IP PORTAL Avialable From:  https:\/\/ipcpub.wipo.int\/2023"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.5772\/68102","author":"Kumazawa R.","year":"2017","unstructured":"Kumazawa R.;  Patenting in the Pharmaceutical Industry Intellectual Property Rights  2017","journal-title":"Patenting in the Pharmaceutical Industry Intellectual Property Rights"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.labeco.2009.09.003","volume":"17","author":"Mukherjee A.","year":"2010","unstructured":"Mukherjee A.; Licensing a new product: Fee vs. royalty licensing with unionized labor market. Labour Econ  2010,17(4),735-742","journal-title":"Labour Econ"},{"year":"2023","key":"ref=12","unstructured":"Cosmetics regulation. Ministry of Food and Drug Safety Avialable From:  https:\/\/www.mfds.go.kr\/eng\/wpge\/m_24\/de011014l001.do2023"},{"key":"ref=13","author":"Weir C.B.","year":"2022","unstructured":"Weir C.B.; Le J.K.;  Metronidazole  2022","journal-title":"Metronidazole"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0190-9622(88)70079-1","volume":"18","author":"Lin A.N.","year":"1988","unstructured":"Lin A.N.; Reimer R.J.; Carter D.M.; Sulfur revisited. J Am Acad Dermatol  1988,18(3),553-558","journal-title":"J Am Acad Dermatol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40257-018-0345-x","volume":"19","author":"Trivedi M.K.","year":"2018","unstructured":"Trivedi M.K.; Bosanac S.S.; Sivamani R.K.; Larsen L.N.; Emerging therapies for acne vulgaris. Am J Clin Dermatol  2018,19(4),505-516","journal-title":"Am J Clin Dermatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.15043","volume":"32","author":"Dr\u00e9no B.","year":"2018","unstructured":"Dr\u00e9no B.; P\u00e9castaings S.; Corvec S.; Veraldi S.; Khammari A.; Roques C.; Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: A brief look at the latest updates. J Eur Acad Dermatol Venereol  2018,32(Suppl. 2),5-14","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1185\/03007999909116500","volume":"15","author":"Bannatyne R.M.","year":"1999","unstructured":"Bannatyne R.M.; Metronidazole, its bioactive metabolites and acne. Curr Med Res Opin  1999,15(4),298-299","journal-title":"Curr Med Res Opin"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1346-8138.2010.01109.x","volume":"38","author":"Song M.","year":"2011","unstructured":"Song M.; Seo S.H.; Ko H.C.; Oh C.K.; Kwon K.S.; Chang C.L.; Kim M.B.; Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. J Dermatol  2011,38(7),667-673","journal-title":"J Dermatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jiac.2015.12.010","volume":"22","author":"Okamoto K.","year":"2016","unstructured":"Okamoto K.; Ikeda F.; Kanayama S.; Nakajima A.; Matsumoto T.; Ishii R.; Umehara M.; Gotoh N.; Hayashi N.; Iyoda T.; Matsuzaki K.; Matsumoto S.; Kawashima M.; In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method. J Infect Chemother  2016,22(6),426-429","journal-title":"J Infect Chemother"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00253-013-5394-8","volume":"98","author":"Wang Y.","year":"2014","unstructured":"Wang Y.; Kuo S.; Shu M.; Yu J.; Huang S.; Dai A.; Two A.; Gallo R.L.; Huang C.M.; Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: Implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol  2014,98(1),411-424","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/18755305MTAwENDE80","volume":"27","author":"Kaur-Boparai J.","year":"2020","unstructured":"Kaur-Boparai J.; Sharma P.K.; Mini review on antimicrobial peptides, sources, mechanism and recent applications. Protein Pept Lett  2020,27(1),4-16","journal-title":"Protein Pept Lett"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/03009734.2014.899278","volume":"119","author":"Malmsten M.","year":"2014","unstructured":"Malmsten M.; Antimicrobial peptides. Ups J Med Sci  2014,119(2),199-204","journal-title":"Ups J Med Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jdv.14374","volume":"31","author":"Dr\u00e9no B.","year":"2017","unstructured":"Dr\u00e9no B.; What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol  2017,31(Suppl. 5),8-12","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2006.00156.x","volume":"257","author":"Marta Guarna M.","year":"2006","unstructured":"Marta Guarna M.; Coulson R.; Rubinchik E.; Anti-inflammatory activity of cationic peptides: Application to the treatment of acne vulgaris. FEMS Microbiol Lett  2006,257(1),1-6","journal-title":"FEMS Microbiol Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40257-014-0099-z","volume":"15","author":"Das S.","year":"2014","unstructured":"Das S.; Reynolds R.V.; Recent advances in acne pathogenesis: Implications for therapy. Am J Clin Dermatol  2014,15(6),479-488","journal-title":"Am J Clin Dermatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1365-2133.2005.06933.x","volume":"153","author":"Jugeau S.","year":"2005","unstructured":"Jugeau S.; Tenaud I.; Knol A.C.; Jarrousse V.; Quereux G.; Khammari A.; Dreno B.; Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol  2005,153(6),1105-1113","journal-title":"Br J Dermatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","volume":"169","author":"Kim J.","year":"2002","unstructured":"Kim J.; Ochoa M.T.; Krutzik S.R.; Takeuchi O.; Uematsu S.; Legaspi A.J.; Brightbill H.D.; Holland D.; Cunliffe W.J.; Akira S.; Sieling P.A.; Godowski P.J.; Modlin R.L.; Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol  2002,169(3),1535-1541","journal-title":"J Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-immunol-042617-053253","volume":"36","author":"Matsuzawa-Ishimoto Y.","year":"2018","unstructured":"Matsuzawa-Ishimoto Y.; Hwang S.; Cadwell K.; Autophagy and Inflammation. Annu Rev Immunol  2018,36(1),73-101","journal-title":"Annu Rev Immunol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/jocd.13636","volume":"20","author":"Lee Y.","year":"2021","unstructured":"Lee Y.; Shin K.; Shin K.O.; Yoon S.; Jung J.; Hwang E.; Chung H.J.; Hossini A.M.; Zouboulis C.C.; Baek M.J.; Baek J.H.; Chi Y.M.; Lee S.; Jeong S.; Topical application of autophagy\u2010activating peptide improved skin barrier function and reduced acne symptoms in acne\u2010prone skin. J Cosmet Dermatol  2021,20(3),1009-1016","journal-title":"J Cosmet Dermatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"69-80, 73-76, 79","DOI":"10.3810\/pgm.2000.03.945","volume":"107","author":"Johnson B.A.","year":"2000","unstructured":"Johnson B.A.; Nunley J.R.; Topical therapy for acne vulgaris. Postgrad Med  2000,107(3),69-80, 73-76, 79-80","journal-title":"Postgrad Med"},{"year":"2022","key":"ref=31","unstructured":"Cosmetics and U.S. Law. Food and Drug Administration FDA Avialable from:  https:\/\/www.fda.gov\/cosmetics\/cosmetics-laws-regulations\/cosmetics-us-law2022"},{"year":"2020","author":"Jeong S.","key":"ref=32","unstructured":"Jeong S.; Gue S.D.; Cha J.D.; Ko E.S.; Cho S.M.; Jung J.H.; Composition for the treatment or improvement of Acne dermatitis comprising 5-aminolevulinic acid hydrochloride and its derivatives.  2020"},{"year":"2020","author":"Keedon P.","key":"ref=33","unstructured":"Keedon P.; Chung H.J.; Heungjae K.; Kayoung S.; Juyeon J.; Beomcheol K.; Beomcheol, A cosmetic and pharmaceutical composition for acne improvement.  2020"},{"year":"2019","author":"Chul H.K.","key":"ref=34","unstructured":"Chul H.K.; Yang K.T.; Mong L.C.; Kook L.K.; A cosmetic composition for reducing acne and inhibiting sebum secretion containing chrysophanol mangiferin and shikonofuran A.  2019"},{"year":"2020","author":"Masatoshi H.","key":"ref=35","unstructured":"Masatoshi H.; Keita M.; Acne bacteria biofilm destructive composition.  2020"},{"year":"2016","author":"Liu Y.","key":"ref=36","unstructured":"Liu Y.; Acne removing and whitening lotion and preparation method thereof.  2016"},{"year":"2018","author":"Yinglu Z.","key":"ref=37","unstructured":"Yinglu Z.; Acne-removing composition and preparation method thereof.  2018"},{"year":"2020","author":"Xiaohui C.","key":"ref=38","unstructured":"Xiaohui C.; Jian C.; Tianhui X.; Lijin Q.; Lijing B.; Antibacterial and anti-inflammation pyridone composition and cosmetic comprising same.  2020"},{"year":"2020","author":"Maga\u00f1a Castro J.A.","key":"ref=39","unstructured":"Maga\u00f1a Castro J.A.; V\u00e1zquez Cervantes L.; Pe\u00f1a S.P.; Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne.  2020"},{"year":"2016","author":"Rudolph T.","key":"ref=40","unstructured":"Rudolph T.; Mueller T.; Use of cyclohexanol derivatives as antimicrobial active ingredients.  2016"},{"year":"2016","author":"Masatoshi H.","key":"ref=41","unstructured":"Masatoshi H.; Matsushita R.; Miyama K.; Biofilm formation inhibitor.  2016"},{"year":"2018","author":"Young Mog K.","key":"ref=42","unstructured":"Young Mog K.; Hwan O. J.; Jung Won K.; Composition for preventing or treating Acne containing oligo-chitosan as an effective component.  2018"},{"year":"2016","author":"Soung M. G.","key":"ref=43","unstructured":"Soung M. G.; Choi W. S.; Jun S.J.; Jeong Y. P.; Cosmetic composition for treating acne.  2016"},{"year":"2018","author":"Jeung P.H.","key":"ref=44","unstructured":"Jeung P.H.; Composition for improving skin acne comprising quercetin and vitamin D.  2018"},{"year":"2016","author":"Dabney P.","key":"ref=45","unstructured":"Dabney P.; Methods for treating acne vulgaris.  2016"},{"year":"2018","author":"Bommagani M.","key":"ref=46","unstructured":"Bommagani M.; Bhowmick S. B.; Kane P.; Dubey V.; Nanoparticulate composition.  2018"},{"year":"2019","author":"Ping L.","key":"ref=47","unstructured":"Ping L.; Morten O.; Hasling Frandsen C.; Hanne M.; Non-aqueous topical compositions comprising a halogenated salicylanilide.  2019"},{"key":"ref=48","author":"Cheng H.","year":"2017","unstructured":"Cheng H.; Rui H.; Kejian Z.; Polypeptide having anti-bacterial and anti-inflammatory activity and application thereof. CN Patent CN106589088A, CN106589088B  2017","journal-title":"CN Patent CN106589088A, CN106589088B"},{"year":"2020","author":"Caires C.","key":"ref=49","unstructured":"Caires C.; Systems and methods for treating and\/or preventing acne.  2020"},{"year":"2017","author":"Jeffry B. S.","key":"ref=50","unstructured":"Jeffry B. S.; Maxwell S.; Use of anti-bacterial agent for the treatment of epithelial-related conditions.  2017"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230817155906","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/219939\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230817155906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T12:46:08Z","timestamp":1716209168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/219939\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":50,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230817155906","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}